Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Synapse (New York, N.Y.)|July 3, 2007
Amphetamine sensitization elevates CaMKIIbeta mRNARachel Greenstein, Gabriela Novak, Philip Seeman
Synapse (New York, N.Y.)|February 26, 2008
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effectsNicola Simola, Micaela Morelli, Philip Seeman
Synapse (New York, N.Y.)|June 5, 2010
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesiaSheng Chen, Philip Seeman, Fang Liu
Synapse (New York, N.Y.)|July 23, 2003
Schizophrenia hippocampus has elevated expression of chondrex glycoprotein geneCarmen Chung, Teresa Tallerico, Philip Seeman
Synapse (New York, N.Y.)|June 27, 2003
Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomographyPhilip Seeman, Teresa Tallerico, Françoise Ko
Synapse (New York, N.Y.)|November 15, 2007
Memantine agonist action at dopamine D2High receptorsPhilip Seeman, Carla Caruso, Mercedes Lasaga
Synapse (New York, N.Y.)|November 15, 2007
Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268Philip Seeman, Carla Caruso, Mercedes Lasaga
Synapse (New York, N.Y.)|May 23, 2006
Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamineFrançoise Ko, Teresa Tallerico, Philip Seeman
The International Journal of Neuroscience|October 15, 2010
Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivityGabriela Novak, Philip Seeman, Bernard Le Foll
Behavioral Neuroscience|October 3, 2007
Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD)Melissa L Perreault, Philip Seeman, Henry Szechtman
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Synapse (New York, N.Y.)|July 3, 2007
Amphetamine sensitization elevates CaMKIIbeta mRNARachel Greenstein, Gabriela Novak, Philip Seeman
Synapse (New York, N.Y.)|February 26, 2008
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effectsNicola Simola, Micaela Morelli, Philip Seeman
Synapse (New York, N.Y.)|June 5, 2010
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesiaSheng Chen, Philip Seeman, Fang Liu
Synapse (New York, N.Y.)|July 23, 2003
Schizophrenia hippocampus has elevated expression of chondrex glycoprotein geneCarmen Chung, Teresa Tallerico, Philip Seeman
Synapse (New York, N.Y.)|June 27, 2003
Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomographyPhilip Seeman, Teresa Tallerico, Françoise Ko
Synapse (New York, N.Y.)|November 15, 2007
Memantine agonist action at dopamine D2High receptorsPhilip Seeman, Carla Caruso, Mercedes Lasaga
Synapse (New York, N.Y.)|November 15, 2007
Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268Philip Seeman, Carla Caruso, Mercedes Lasaga
Synapse (New York, N.Y.)|May 23, 2006
Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamineFrançoise Ko, Teresa Tallerico, Philip Seeman
The International Journal of Neuroscience|October 15, 2010
Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivityGabriela Novak, Philip Seeman, Bernard Le Foll
Behavioral Neuroscience|October 3, 2007
Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD)Melissa L Perreault, Philip Seeman, Henry Szechtman
Pageof 9